Suchergebnisse - "Scheetz, Marc H."

PubPharm (10)

1

Clinical Pharmacokinetics and Pharmacodynamics of Cefepime

enthalten in: Clinical pharmacokinetics | 2022

von Pais, G. | Chang, J. | Barreto, E. | +9

2

Cefepime Precision Dosing Tool : from Standard to Precise Dose Using Nonparametric Population Pharmacokinetics

enthalten in: Antimicrobial agents and chemotherapy | 2022

von Alshaer, M. | Goutelle, S. | Santevecchi, B. | +10

3

Clinical pharmacokinetics of ceftolozane and tazobactam in an obese patient receiving continuous venovenous haemodiafiltration : A patient case and literature review

enthalten in: Journal of global antimicrobial resistance | 2020

von Mahmoud, A. | Shah, A. | Nutley, K. | +5

4

Defining the impact of severity of illness on time above the MIC threshold for cefepime in Gram-negative bacteraemia : a 'Goldilocks' window

enthalten in: International journal of antimicrobial agents | 2017

von Miglis, C. | Rhodes, N. | Kuti, J. | +3

5

Population pharmacokinetics of cefepime in febrile neutropenia : implications for dose-dependent susceptibility and contemporary dosing regimens

enthalten in: International journal of antimicrobial agents | 2017

von Rhodes, N. | Grove, M. | Kiel, P. | +5

6

Pharmacokinetics of Cefepime in Patients with Cancer and Febrile Neutropenia in the Setting of Hematologic Malignancies or Hematopoeitic Cell Transplantation

enthalten in: Pharmacotherapy | 2016

von Whited, L. | Grove, M. | Rose, D. | +9

7

An exploratory analysis of the ability of a cefepime trough concentration greater than 22 mg/L to predict neurotoxicity

enthalten in: Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy | 2016

von Rhodes, N. | Kuti, J. | Nicolau, D. | +3

8

Defining Clinical Exposures of Cefepime for Gram-Negative Bloodstream Infections That Are Associated with Improved Survival

enthalten in: Antimicrobial agents and chemotherapy | 2015

von Rhodes, N. | Kuti, J. | Nicolau, D. | +6

9

Evaluation of clinical outcomes in patients with Gram-negative bloodstream infections according to cefepime MIC

enthalten in: Diagnostic microbiology and infectious disease | 2015

von Rhodes, N. | Liu, J. | McLaughlin, M. | +2

10

Unacceptably high error rates in Vitek 2 testing of cefepime susceptibility in extended-spectrum-β-lactamase-producing Escherichia coli

enthalten in: Antimicrobial agents and chemotherapy | 2014

von Rhodes, N. | Richardson, C. | Heraty, R. | +4

1
[1]